« Kidney Damage after Heart Surgery on the Rise | Main

Trasylol Removed from the Market

Read about why the FDA announced on November 5, 2007, that Bayer Pharmaceuticals Corp. will cease the marketing and sale of Trasylol. Learn about Trasylol Lawsuits from Trasylol Lawyers.

Aprotinin lawyers believe that once FDA sees the Trasylol data from the BART study, it will limit when Trasylol could still be used. When the benefits of Trasylol outweigh the risks, individual doctors can to identify specific cases where Trasylol will be used in patients in the future.

Posted by Michael Monheit on November 5, 2007 01:21 PM |

TrackBack

TrackBack URL for this entry:
http://blogs.legalview.com/mt-admin/mt-tb.cgi/1852

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)